BioCentury | Mar 17, 2003
Company News

Theryte, Randox Laboratories deal

...The companies will develop early-stage cancer diagnostic tests using TheRyte’s protein biochip array technology. Randox is...
...the tests. Randox also took an equity stake in TheRyte through a separate cash investment. TheRyte Ltd....
BioCentury | Mar 14, 2003
Company News

TheRyte, Randox diagnostics deal

...TheRyte (Liverpool, U.K.) and Randox (Crumlin, U.K.) partnered to develop early-stage cancer diagnostic tests using TheRyte's...
...manufacturer, is responsible for validating and commercializing the tests and made an equity stake in TheRyte. BC...
Items per page:
1 - 2 of 2
BioCentury | Mar 17, 2003
Company News

Theryte, Randox Laboratories deal

...The companies will develop early-stage cancer diagnostic tests using TheRyte’s protein biochip array technology. Randox is...
...the tests. Randox also took an equity stake in TheRyte through a separate cash investment. TheRyte Ltd....
BioCentury | Mar 14, 2003
Company News

TheRyte, Randox diagnostics deal

...TheRyte (Liverpool, U.K.) and Randox (Crumlin, U.K.) partnered to develop early-stage cancer diagnostic tests using TheRyte's...
...manufacturer, is responsible for validating and commercializing the tests and made an equity stake in TheRyte. BC...
Items per page:
1 - 2 of 2